logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Dingwei Ye

beijing institute of technology

37H-index
318Paper Count
1.0WCitation Count
Published Papers 94
Publication Date
logo
METTL5-mediated rRNA modification controls prostate cancer progression through the IRF7/DNA2 axis and mitophagy regulation
errOncogene
IF7.3
err2026-07-13
err0
PREAI
errRuifeng Yang; Qintao Ge; Fengyao Wu; Manmei Long; Bingyu Li; Zhe Hong; Wenhao Xu; Miaomiao Guo; Tao Feng; Xi Tian; Wei Zhang; Kun Chang; Fangning Wan; Zhi Shang; Zhongyuan Wang; Ming Zhan; Bin Xu; Dingwei Ye
errShare
errSave
Flexible Waterborne Acoustic Metasurface With Tunable Functionality
errJOURNAL OF APPLIED MECHANICS-TRANSACTIONS OF THE ASME
IF2.8
err2026-06-01
err0
PREAI
errLiu, Runquan; Liu, Hao; Ye, Dingwei; Yan, Dong; Jian, Nannan; Zhang, Kai
errShare
errSave
Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations
errNature Communications
IF15.7
err2026-04-18
err0
errOAAI
errHongji Dai; Xinlei Chu; Han Du; Shutong Yang; Yanxin Yao; Xinru Yu; Yanrui Zhao; Pei Dong; Zhangyan Lyu; Wei Wang; Haixin Li; Zeyun Mi; Chao Sheng; Xiangchun Li; Hong Zheng; Fangfang Song; Fengju Song; Menghong Sun; Juncheng Dai; Qing Lan; Nathaniel Rothman; Zhibin Hu; Qingyi Wei; Dingwei Ye; Xin Yao; Weihua Jia; Stephen J. Chanock; Hongbing Shen; Mark P. Purdue; Mulin Jun Li; Kexin Chen
errShare
errSave
Development and prospective validation of a multitarget urine RNA assay for noninvasive detection of urothelial carcinoma
erriScience
IF4.1
err2025-11-19
err0
errOAAI
errHua Xu; Shuai Wang; Dingwei Xue; Zhihui Xu; Qi Zhang; Qijun Wo; Banggao Huang; Zujie Mao; Feng Liu; Shuixin Lou; Jie Yuan; Shibin Zhu; Lifeng Ding; Yixin Wo; Zhengzhi Luo; Jinying Chen; Qinghua Xu; Gonghui Li; Xiaolong Qi; Dingwei Ye
errShare
errSave
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer
errFrontiers in Cell and Developmental Biology
IF4.3
err2025-11-04
err0
errOAAI
errZhongyuan Wang†; Qintao Ge†; Anwaier Aihetaimujiang†; Ji Zhang†; Jiahe Lu; Jianfeng Yang; Yonghao Chen; Bin Qin; Hailiang Zhang; Wen-Hao Xu; Dingwei Ye
errShare
errSave
Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 Phase III study
errAnnals of Oncology
IF65.4
err2025-10-19
err0
errOAAI
errKarim Fizazi; Noel W. Clarke; Maria De Santis; Hirotsugu Uemura; Andre P. Fay; Nuri Karadurmus; Mariusz Kwiatkowski; Carlos Alvarez-Fernandez; Shusuan Jiang; Miguel Sotelo; Dominique Parslow; Niara Oliveira; Tae Gyun Kwon; Dingwei Ye; Steve Boudewijns; Pongwut Danchaivijitr; Claire Rooney; Christopher Gresty; Marc Yeste-Velasco; Jill Logan; Daniel J. George
errShare
errSave
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err10
PREAI
errPowles, Thomas; Kann, Ariel G.; Castellano, Daniel; Gross-Goupil, Marine; Nishiyama, Hiroyuki; Bracarda, Sergio; Bjerggaard Jensen, Jorgen; Makaroff, Lydia; Jiang, Shusuan; Ku, Ja Hyeon; Park, Se Hoon; Reig Torras, Oscar; Ye, Dingwei; Maruzzo, Marco; Necchi, Andrea; Morales-Barrera, Rafael; Giunta, Emilio Francesco; Lee, Jae Lyun; Tortora, Giampaolo; Urun, Yuksel; Dolowy, Lukasz; Erdem, Dilek; Pinto, Alvaro; Grando, Fabricio; Zou, Wei; Assaf, Zoe June; Vuky, Jacqueline; Degaonkar, Viraj; Steinberg, Elizabeth E.; Bellmunt, Joaquim; Gschwend, Jurgen E.
errShare
errSave
KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer
errOncogene
IF7.3
err2025-09-23
err0
errOAAI
errHaoyue Sheng; Guohai Shi; Yawen Lu; Shengfeng Zheng; Weijie Gu; Dan Xia; Haojie Huang; Dingwei Ye
errShare
errSave
Proteogenomic Analysis Identifies Clinically Relevant Subgroups of Collecting Duct Carcinoma
errResearch
IF10.7
err2025-09-03
err0
errOAAI
errYuanyuan Qu; Xiaoru Pei; Jinwen Feng; Xin Yan; Linhui Zhang; Jun Wang; Xin Yao; Jiasheng Bian; Yu Gan; Hualei Gan; Xuewen Jiang; Ping Yang; Maoping Cai; Liqing Li; Xinqiang Wu; Weiwei Jing; Chao Zhang; Jianyuan Zhao; Hailiang Zhang; Guohai Shi; Xiang Zhou; Dingwei Ye; Chen Ding
errShare
errSave
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
errNature Medicine
IF50
err2025-08-07
err0
PREAI
errMatthew D. Galsky; Dean F. Bajorin; Yoshihiko Tomita; Dingwei Ye; Mads Agerbaek; Deborah Enting; Avivit Peer; Matthew Milowsky; Ko Kobayashi; Marc-Oliver Grimm; Frank Stenner; Justin M. David; Jun Li; Scott D. Chasalow; Federico Nasroulah; Abraham Apfel; Keziban Ünsal-Kaçmaz; Andrea Necchi
errShare
errSave
Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
errNature Medicine
IF50
err2025-07-21
err0
errOAAI
errNeal D. Shore; Thomas B. Powles; Jens Bedke; Matthew D. Galsky; Joan Palou Redorta; Ja Hyeon Ku; Michal Kretkowski; Evanguelos Xylinas; Boris Alekseev; Dingwei Ye; Félix Guerrero-Ramos; Alberto Briganti; Girish S. Kulkarni; Julia Brinkmann; Anna-Maria Calella; Rossano Cesari; Anthony Eccleston; Elisabete Michelon; Jennifer Vermette; Caimiao Wei; Gary D. Steinberg
errShare
errSave
A randomized study of apalutamide in Chinese patients with non-metastatic castration-resistant prostate cancer
erriScience
IF4.1
err2025-07-18
err0
errOAAI
errShusuan Jiang; Ye Tian; Hongqian Guo; Jianming Guo; Haiying Dong; Hong Luo; Wei Xue; Tao Xu; Lei Li; Mingxing Qiu; Liping Xie; Angela Lopez-Gitlitz; Sharon McCarthy; Yanmei Liu; Haocheng Ma; Hongchuan Liang; Yanhui Li; Na Chen; Dingwei Ye
errShare
errSave
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial
errlancet
IF0
err2025-07-16
err0
PREAI
errKarim Fizazi; Arun A Azad; Nobuaki Matsubara; Joan Carles; André P Fay; Ugo De Giorgi; Jae Young Joung; Peter C C Fong; Eric Voog; Robert J Jones; Neal D Shore; Curtis Dunshee; Stefanie Zschäbitz; Jan Oldenburg; Dingwei Ye; Xun Lin; Matko Kalac; A Douglas Laird; Dana Kennedy; Neeraj Agarwal
errShare
errSave
Comprehensive analysis of the LINC01122/TPD52 axis as a predictive biomarker in prostate adenocarcinoma
errSCIENTIFIC REPORTS
IF3.9
err2025-05-08
err0
errOAAI
errShang, Zhi; Jin, Shengming; He, Yandong; Zhu, Yiping; Zhang, Hailiang; Wu, Junlong; Hong, Zhe; Ye, Dingwei
errShare
errSave
UFO registry: final analysis of baseline data from patients with advanced prostate cancer in Asia
errTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
err2024-11-23
err0
errOAAI
errYe, Dingwei; Kanesvaran, Ravindran; Chiong, Edmund; Lojanapiwat, Bannakij; Pu, Yeong-Shiau; Rawal, Sudhir Kumar; Aik, Ong Teng; Zeng, Hao; Chung, Byung Ha; Ashani, Md Yusoff Noor; Ohyama, Chikara; Kim, Choung Soo; Hu, Zhiquang; Tsai, Yuh-Shyan; Razack, Azad Hassan Abdul; Singh, Anildeep; Liu, Yanfang; Uemura, Hirotsugu
errShare
errSave
MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway
errCELL COMMUNICATION AND SIGNALING
IF8.9
err2024-10-24
err0
errOAAI
errZheng, Shengfeng; Hong, Zhe; Tan, Yao; Wang, Yue; Li, Junhong; Zhang, Zihao; Feng, Tao; Hong, Zongyuan; Lin, Guowen; Ye, Dingwei
errShare
errSave
Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma
errCLINICAL AND EXPERIMENTAL MEDICINE
IF3.5
err2024-07-06
err3
errOAAI
errWu, Gengrun; Li, Teng; Chen, Yuanbiao; Ye, Shiqi; Zhou, Siqi; Tian, Xi; Anwaier, Aihetaimujiang; Zhu, Shuxuan; Xu, Wenhao; Hao, Xiaohang; Ye, Dingwei; Zhang, Hailiang
errShare
errSave
Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models
errONCOGENE
IF7.3
err2024-06-17
err2
PREAI
errLin, Guowen; Zhang, Feng; Weng, Xiaoling; Hong, Zhe; Ye, Dingwei; Wang, Gangmin
errShare
errSave
Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy
errBMC CANCER
IF3.4
err2024-05-25
err1
errOAAI
errWang, Beihe; Pan, Jian; Zhang, Tingwei; Ni, Xudong; Wei, Yu; Li, Xiaomeng; Fang, Bangwei; Hu, Xiaoxin; Gan, Hualei; Wu, Junlong; Wang, Hongkai; Ye, Dingwei; Zhu, Yao
errShare
errSave
Network meta-analysis of combination strategies in metastatic hormone-sensitive prostate cancer
errASIAN JOURNAL OF ANDROLOGY
IF2.7
err2024-04-12
err1
errOAAI
errWang, Shan-Shan; Bian, Xiao-Jie; Wu, Jun-Long; Wang, Bei-He; Zhang, Sheng; Ye, Ding-Wei
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
王
王军 (Jun Wang)
H-index: 222 · Papers: 3.2K
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
H
Huanming Yang
H-index: 171 · Papers: 1.1K
S
Stephen J. Chanock
H-index: 170 · Papers: 2.2K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
View more